Priority Research Program (PRP) on Antibiotic Resistance

The aim of the National Antibiotic Resistance Interface is to raise the profile of French research into antibiotic resistance, and to provide access to all the research and information carried out by research alliances (AllEnvi, Aviesan and Athena), research organizations and institutes, including their laboratories and platforms, structures and infrastructures funded as part of the “Investissements d'Avenir” program, funding agencies, European and international initiatives, industrial players (manufacturers and start-ups), healthcare industry unions, clinical trials, and to facilitate and ensure the continuity and sharing of information issued by the ministries and Santé publique France in charge of surveillance.

In three points, we aim to:

• identify all the forces at work in fundamental, environmental, veterinary, clinical and cross-disciplinary research, public health, human sciences, economics and social sciences, including both emerging (SMEs, ETIs) and established (pharmaceutical and veterinary companies) industrial players

• develop and maintain an open-access, interoperable database of all players and funded research programs (public-private) involving calls for expressions of interest or resistance projects

• bring together and interconnect the very wide range of skills and expertise present in the region, to facilitate the coordination of research activities around consensual actions in a “one health” approach between public and private sector players and/or patient associations and the French Health Insurance.